HORA-CHM

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameHORA-CHM
Drug Alias NameAAV5-CHM gene therapy (Horama)HORA-CHM
ClassificationBiologics
Mechanisms of ActionRab proteins geranylgeranyltransferase component A 1 gene transference
TargetsRab proteins geranylgeranyltransferase component A 1
Therapy Area/IndicationsChoroideremia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCoave Therapeutics SA
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCoave Therapeutics SA
Active IndicationsN/A
Inactive IndicationsChoroideremia

Other Information

ATC CodeN/A
Related LinksN/A